Skip to main content

Displaying 1981 - 1992 of 4555

Breadth Improvement? Or Just Less Bad?

October 15, 2022

In yesterday's note we talked about how the Dow Jones Industrial Average went up in price for the 2nd consecutive week. This isn't something we've seen happen too often in 2022.

But what else happened this week?

Well, we got fewer stocks making new 52-week lows on the NYSE. The peak in new lows was back in June, which was 4 months ago.

You can see it in shorter-time horizons as well. Look at the S&P500 new 63 day low list continuing to deteriorate (63 days = 3 months = 1 quarter):

All Star Charts Premium

International Hall of Famers (10-14-2022)

October 14, 2022

From the Desk of Steve Strazza @Sstrazza and Alfonso Depablos @AlfCharts

Our International Hall of Famers list is composed of the 100 largest US-listed international stocks, or ADRs. We’ve also sprinkled in some of the largest ADRs from countries that did not make the market cap cut. 

These stocks range from some well-known mega-cap multinationals such as Toyota Motor and Royal Dutch Shell to some large-cap global disruptors such as Sea Ltd and Shopify.

It’s got all the big names and more--but only those that are based outside the US. You can find all the largest US stocks on our original Hall of Famers list.

The beauty of these scans is really in their simplicity.

We take the largest names each week and then apply technical filters in a way that the strongest stocks with the most momentum rise to the top.

Based on the market environment, we can also flip the scan on its head and filter for weakness.

Let’s dive in and take a look at some of the most important stocks from around the world.

Here’s this week’s list:

Chart of the Day: Major Market Trends

October 14, 2022

There are a lot of trends in markets that are worth paying attention to.

Remember, asset prices trend. They're not random.

We have the data.

So one major trend we want to make sure we're not ignoring is in Energy stocks relative to Technology.

Look at the ratio between them making new multi-year highs, yet the S&P500 weighting in energy is still less than 5% of the entire index. But Technology is still almost 25% of the index.

Is that weighting sustainable?

All Star Charts Premium

Young Aristocrats (October 2022)

October 13, 2022

From the desk of Steve Strazza @Sstrazza

Dividend Aristocrats are easily some of the most desirable investments on Wall Street. These are the names that have increased dividends for at least 25 years, providing steadily increasing income to long-term-minded shareholders.

As you can imagine, the companies making up this prestigious list are some of the most recognizable brands in the world. Coca-Cola, Walmart, and Johnson & Johnson are just a few of the household names making the cut.

Here at All Star Charts, we like to stay ahead of the curve. That's why we're turning our attention to the future aristocrats. In an effort to seek out the next generation of the cream-of-the-crop dividend plays, we're curating a list of stocks that have raised their payouts every year for five to nine years.

We call them the Young Aristocrats, and the idea is that these are "stocks that pay you to make money." Imagine if years of consistent dividend growth and high momentum and relative strength had a baby, leaving you with the best of the emerging dividend giants that are outperforming the averages.

Swing Trader Pro: Morning Briefing (10-13-2022)

October 13, 2022

From the Desk of Kimmy Sokoloff

As I write this morning, the futures are trading higher, with the SPX at 3,600 ahead of the release of September CPI data.

I'd like to see the SPX hold onto 3,600 and trend higher from here, but time will tell.

The levels to watch on the $SPY are support at 355.71, then 354.15. Resistance is  is 360, then 364.

Viking Global Now Owns 17% of INBX

October 13, 2022

The largest insider transaction on today's list is a Form 4 filing by the Greenwich-based hedge fund Viking Global Investors.

The fund reported a purchase worth roughly $40 million in the small-cap biotech Inhibrx $INBX, increasing its total stake to 17%.